We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » JUDGE INVALIDATES OXYCONTIN PATENTS, CLEARS ENDO'S GENERIC
A federal judge has cleared the way for generic firm Endo Pharmaceuticals to launch a version of Purdue Pharma’s pain treatment OxyContin, ruling that patents on the brand product were unenforceable.